Skip to main content
. 2019 May 3;11(5):213. doi: 10.3390/pharmaceutics11050213

Figure 6.

Figure 6

XRD difractograms (A) and FTIR spectra (B) of Paclitaxel and TEHA-co-PDLLA nanoparticles.